American Century Companies’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.1K | Sell |
16,936
-8,038
| -32% | -$13.8K | ﹤0.01% | 2843 |
|
|
2025
Q1 | $83.2K | Sell |
24,974
-101,680
| -80% | -$339K | ﹤0.01% | 2836 |
|
|
2024
Q4 | $937K | Sell |
126,654
-72,020
| -36% | -$533K | ﹤0.01% | 2278 |
|
|
2024
Q3 | $1.87M | Sell |
198,674
-4,364
| -2% | -$41K | ﹤0.01% | 1988 |
|
|
2024
Q2 | $1.63M | Sell |
203,038
-135,478
| -40% | -$1.09M | ﹤0.01% | 1982 |
|
|
2024
Q1 | $5.02M | Buy |
338,516
+5,380
| +2% | +$79.7K | ﹤0.01% | 1450 |
|
|
2023
Q4 | $2.71M | Sell |
333,136
-75,622
| -19% | -$615K | ﹤0.01% | 1645 |
|
|
2023
Q3 | $1.86M | Sell |
408,758
-8,407
| -2% | -$38.3K | ﹤0.01% | 1725 |
|
|
2023
Q2 | $2.94M | Buy |
417,165
+97,855
| +31% | +$689K | ﹤0.01% | 1509 |
|
|
2023
Q1 | $1.95M | Buy |
319,310
+1,649
| +0.5% | +$10.1K | ﹤0.01% | 1618 |
|
|
2022
Q4 | $2.03M | Sell |
317,661
-152,927
| -32% | -$977K | ﹤0.01% | 1543 |
|
|
2022
Q3 | $4.51M | Buy |
470,588
+5,504
| +1% | +$52.7K | ﹤0.01% | 1154 |
|
|
2022
Q2 | $5.13M | Buy |
465,084
+56,194
| +14% | +$620K | ﹤0.01% | 1110 |
|
|
2022
Q1 | $6.81M | Buy |
408,890
+357
| +0.1% | +$5.94K | ﹤0.01% | 1023 |
|
|
2021
Q4 | $7.8M | Buy |
408,533
+31,379
| +8% | +$599K | ﹤0.01% | 948 |
|
|
2021
Q3 | $9.3M | Buy |
377,154
+65
| +0% | +$1.6K | 0.01% | 863 |
|
|
2021
Q2 | $9.81M | Buy |
377,089
+7,560
| +2% | +$197K | 0.01% | 819 |
|
|
2021
Q1 | $11.7M | Buy |
369,529
+24,141
| +7% | +$764K | 0.01% | 749 |
|
|
2020
Q4 | $16M | Buy |
345,388
+218,004
| +171% | +$10.1M | 0.01% | 670 |
|
|
2020
Q3 | $4.19M | Sell |
127,384
-31,232
| -20% | -$1.03M | ﹤0.01% | 825 |
|
|
2020
Q2 | $4.35M | Sell |
158,616
-156,340
| -50% | -$4.29M | ﹤0.01% | 788 |
|
|
2020
Q1 | $9.43M | Buy |
314,956
+16,912
| +6% | +$506K | 0.01% | 615 |
|
|
2019
Q4 | $8.25M | Buy |
298,044
+103,500
| +53% | +$2.86M | 0.01% | 726 |
|
|
2019
Q3 | $3.54M | Buy |
+194,544
| New | +$3.54M | ﹤0.01% | 877 |
|